Pay in 4 interest-free payments of $5.40 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
[13] [15] Administered as a once-weekly subcutaneous injection, tirzepatide is available in escalating doses from 2.5 mg to 15 mg
"FDA Approves First Medication for Obstructive Sleep Apnea." fda.gov Medicare Interactive / NCOA
If you decide GLP-1 medication is right for you, the Microdose program at $199/month offers the best balance of cost and effectiveness for most people
Signs you should slow down the titration Extend your stay at the current dose by 2-4 additional weeks if you experience any of the following at the end of a standard 4-week period: Nausea persisting beyond the first 7 days after the last dose increase Vomiting more than twice per week Diarrhea lasting more than 10 days at the current dose Significant fatigue or weakness that does not improve with adequate nutrition and rest Weight loss exceeding 1.5% per week (too-rapid loss increases gallstone risk and muscle loss) Slowing the titration is not failure
Even though you may have already adjusted to tirzepatide through the oral route, switching to injectable delivery changes the pharmacokinetic profile
US$ 27.48
US$ 24.58
US$ 28.19
US$ 27.33
US$ 26.54
US$ 28.00
US$ 25.83
US$ 24.60
